Jonathan Khalifa
Overview
Explore the profile of Jonathan Khalifa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
276
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alyamani N, Clementel E, Sargos P, Blanchard P, Supiot S, Ronchin P, et al.
Radiother Oncol
. 2025 Feb;
206:110780.
PMID: 39924002
Purpose: Radiotherapy quality assurance (RTQA) is essential for ensuring adherence to trial protocols. This paper summarizes the individual case review (ICR) results from the PEACE-1 trial, a phase-III study investigates...
2.
Riou O, Hennequin C, Khalifa J, Sargos P
Cancer Radiother
. 2024 Oct;
28(6-7):623-627.
PMID: 39384515
Trimodal therapy consisting of transurethral resection of bladder tumors followed by radiotherapy and chemotherapy, has emerged as a valuable therapeutic alternative to radical cystectomy in patients with muscle invasive bladder...
3.
Sargos P, Xylinas E, Khalifa J
Eur Urol
. 2024 Oct;
87(1):71-72.
PMID: 39379235
No abstract available.
4.
Winock A, Mourey L, Gerard S, Lusque A, Abellan Van Kan G, Lozanno S, et al.
J Geriatr Oncol
. 2024 Aug;
15(7):101834.
PMID: 39097501
No abstract available.
5.
Thareja G, Salvioni A, Lauzeral-Vizcaino F, Halabi N, Mery-Lamarche E, Thebault N, et al.
J Immunother Cancer
. 2024 Jul;
12(7).
PMID: 39009451
Background: Cervical cancer's lymphatic spread primarily begins from the sentinel lymph nodes (SLNs), underlining their pivotal role in disease metastasis. However, these nodes' immune gene expression profiles and immunoregulation mechanisms...
6.
Basse C, Khalifa J, Thillays F, Le Pechoux C, Maury J, Bonte P, et al.
J Thorac Oncol
. 2024 Apr;
19(7):1095-1107.
PMID: 38608932
Introduction: Thymomas are rare intrathoracic malignancies that can relapse after surgery. Whether or not Post-Operative RadioTherapy (PORT) should be delivered after surgery remains a major issue. RADIORYTHMIC is an ongoing,...
7.
Mennecier B, Khalifa J, Descourt R, Greillier L, Naltet C, Falchero L
BMC Cancer
. 2024 Apr;
24(1):421.
PMID: 38580937
Background: We designed this study based on both a physician practice survey and real-world patient data to: (1) evaluate clinical management practices in extensive-stage small cell lung cancer (ES-SCLC) among...
8.
Masson I, Larriviere L, Mahe M, Azria D, Pommier P, Mesgouez-Nebout N, et al.
Clin Transl Radiat Oncol
. 2023 Dec;
44:100702.
PMID: 38111609
Purpose: High-risk (HR) prostate cancer patients usually receive high-dose radiotherapy (RT) using a two-phase sequential technique, but data on a simultaneous integrated boost (SIB) technique are lacking. We prospectively evaluated...
9.
Khalifa J, Thebault N, Scarlata C, Norkowski E, Massabeau C, Brouchet L, et al.
Front Oncol
. 2023 Dec;
13:1269166.
PMID: 38074683
Background: While much progress has been accomplished in the understanding of radiation-induced immune effects in tumors, little is known regarding the mechanisms involved at the tumor draining lymph node (TDLN)...
10.
Laprie A, Noel G, Chaltiel L, Truc G, Sunyach M, Charissoux M, et al.
Neuro Oncol
. 2023 Jul;
26(1):153-163.
PMID: 37417948
Background: Glioblastoma (GBM) systematically recurs after a standard 60 Gy radio-chemotherapy regimen. Since magnetic resonance spectroscopic imaging (MRSI) has been shown to predict the site of relapse, we analyzed the...